Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17)
Diabetic Medicine, 10/02/09
Scheen AJ et al. – Intensifying an existing dual oral therapy regimen to a triple oral regimen by adding pioglitazone to the classical metformin–sulphonylurea combination resulted in sustained improvements in glycaemic control and reduced progression to insulin therapy. The advantages and disadvantages of adding pioglitazone instead of adding basal insulin should be assessed further.
Related Articles
Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 67%
Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes
European Journal of Internal Medicine, 10/12/09
Relevance Score: 67%
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 66%
Tube feeding with a diabetes-specific feed for 12 weeks improves glycaemic control in type 2 diabetes patients
Clinical Nutrition, 10/15/09
Relevance Score: 66%
Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA1c in subjects with Type 2 diabetes
Diabetic Medicine, 10/02/09
Relevance Score: 65%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Pediatrics, 12/11/09
Emerging technologies in the delivery of erythropoietin for therapeutics
Medicinal Research Reviews, 12/11/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease
Expert Opinion in Pharmacotherapy, 12/11/09
Obesity in older adults: relationship to functional limitation
Current Opinion in Clinical Nutrition & Metabolic Care, 12/11/09
Diabetic nephropathy: which teenagers are at risk and how can risk be minimised
Paediatrics and Child Health, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


